Covered recipient · General Payments record
ZULFIQAR RANA
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,622.70
- Reported across 84 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $251.96 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $35.47 | 2 |
| ORGANOGENESIS INC. | $31.07 | 1 |
| Lilly USA, LLC | $29.86 | 2 |
| ABBVIE INC. | $22.77 | 1 |
| Astellas Pharma US Inc | $22.68 | 1 |
| Exact Sciences Corporation | $19.35 | 1 |
| Novo Nordisk AS | $16.54 | 1 |
| Averitas Pharma Inc. | $16.43 | 1 |
| Acerta Pharma LLC | $15.90 | 1 |
| Amgen Inc. | $14.50 | 1 |
| PFIZER INC. | $13.99 | 1 |
| Phathom Pharmaceuticals, Inc. | $13.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.77 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105371170 | CMS |
| Amgen Inc. | $14.50 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117662295 | CMS |
| Astellas Pharma US Inc | $22.68 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139321836 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.90 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105357233 | CMS |
| Averitas Pharma Inc. | $16.43 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133442269 | CMS |
| Exact Sciences Corporation | $19.35 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114847226 | CMS |
| Lilly USA, LLC | $14.85 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135456903 | CMS |
| Lilly USA, LLC | $15.01 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135478692 | CMS |
| Merck Sharp & Dohme LLC | $19.05 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141632849 | CMS |
| Merck Sharp & Dohme LLC | $16.42 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141632847 | CMS |
| Novo Nordisk Inc | $16.54 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096906167 | CMS |
| Organogenesis Inc. | $31.07 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145443785 | CMS |
| PFIZER INC. | $13.99 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131670555 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.40 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151113970 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.